Gupta S, Snow R W, Donnelly C A, Marsh K, Newbold C
Wellcome Trust Centre for Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, UK.
Nat Med. 1999 Mar;5(3):340-3. doi: 10.1038/6560.
In areas of stable transmission, clinical immunity to mild malaria is acquired slowly, so it is not usually effective until early adolescence. Life-threatening disease is, however, restricted to a much younger age group, indicating that resistance to the severe clinical consequences of infection is acquired more quickly. Understanding how rapidly immunity develops to severe malaria is essential, as severe malaria should be the primary target of intervention strategies, and predicting the result of interventions that reduce host exposure will require consideration of these dynamics. Severe disease in childhood is less frequent in areas where transmission is the greatest. One explanation for this is that infants experience increased exposure to infection while they are protected from disease, possibly by maternal antibody. They therefore emerge from this period of clinical protection with considerably more immunity than those who experience lower transmission intensities. Here we use this data, assuming a period of clinical protection, to estimate the number of prior infections needed to reduce the risk of severe disease to negligible levels. Contrary to expectations, one or two successful infective bites seem to be all that is necessary across a broad range of transmission intensities.
在疟疾稳定传播地区,对轻度疟疾的临床免疫力获得缓慢,通常要到青春期早期才会有效。然而,危及生命的疾病多见于年龄小得多的群体,这表明对感染严重临床后果的抵抗力获得得更快。了解对重症疟疾的免疫力发展速度至关重要,因为重症疟疾应是干预策略的主要目标,预测减少宿主接触的干预措施的结果需要考虑这些动态变化。在传播率最高的地区,儿童期的重症疾病较少见。对此的一种解释是,婴儿在受到疾病保护(可能是通过母体抗体)的同时,接触感染的机会增加。因此,与那些经历较低传播强度的婴儿相比,他们在这段临床保护期结束时获得了更强的免疫力。在此,我们利用这些数据,假设存在一段临床保护期,来估计将重症疾病风险降低到可忽略不计的水平所需的既往感染次数。与预期相反,在广泛的传播强度范围内,一两次成功的感染叮咬似乎就足够了。